These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

637 related items for PubMed ID: 29238047

  • 1. Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma.
    Papa E, Weller M, Weiss T, Ventura E, Burghardt I, Szabó E.
    Cell Death Dis; 2017 Dec 13; 8(12):3210. PubMed ID: 29238047
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anti-c-MET Nanobody - a new potential drug in multiple myeloma treatment.
    Slørdahl TS, Denayer T, Moen SH, Standal T, Børset M, Ververken C, Rø TB.
    Eur J Haematol; 2013 Nov 13; 91(5):399-410. PubMed ID: 23952536
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
    Halevy O, Cantley LC.
    Exp Cell Res; 2004 Jul 01; 297(1):224-34. PubMed ID: 15194438
    [Abstract] [Full Text] [Related]

  • 6. Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition.
    Tanahashi T, Osada S, Yamada A, Kato J, Yawata K, Mori R, Imai H, Sasaki Y, Saito S, Tanaka Y, Nonaka K, Yoshida K.
    Int J Oncol; 2013 Feb 01; 42(2):556-64. PubMed ID: 23229794
    [Abstract] [Full Text] [Related]

  • 7. Signaling pathways in the induction of c-met receptor expression by its ligand scatter factor/hepatocyte growth factor in human glioblastoma.
    Abounader R, Ranganathan S, Kim BY, Nichols C, Laterra J.
    J Neurochem; 2001 Mar 01; 76(5):1497-508. PubMed ID: 11238734
    [Abstract] [Full Text] [Related]

  • 8. Matriptase is required for the active form of hepatocyte growth factor induced Met, focal adhesion kinase and protein kinase B activation on neural stem/progenitor cell motility.
    Fang JD, Lee SL.
    Biochim Biophys Acta; 2014 Jul 01; 1843(7):1285-94. PubMed ID: 24685580
    [Abstract] [Full Text] [Related]

  • 9. Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis.
    Cheng N, Chytil A, Shyr Y, Joly A, Moses HL.
    Cancer Res; 2007 May 15; 67(10):4869-77. PubMed ID: 17495323
    [Abstract] [Full Text] [Related]

  • 10. Effects of transforming growth factor-β inhibitor on the proliferation of glioma stem/progenitor cell.
    Zhang Q, Guo W, Di C, Lou M, Li H, Zhao Y.
    Pol J Pathol; 2017 May 15; 68(4):312-317. PubMed ID: 29517201
    [Abstract] [Full Text] [Related]

  • 11. Hepatocyte growth factor regulates proteoglycan synthesis in interstitial fibroblasts.
    Kobayashi E, Sasamura H, Mifune M, Shimizu-Hirota R, Kuroda M, Hayashi M, Saruta T.
    Kidney Int; 2003 Oct 15; 64(4):1179-88. PubMed ID: 12969135
    [Abstract] [Full Text] [Related]

  • 12. Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells.
    Sunayama J, Matsuda K, Sato A, Tachibana K, Suzuki K, Narita Y, Shibui S, Sakurada K, Kayama T, Tomiyama A, Kitanaka C.
    Stem Cells; 2010 Nov 15; 28(11):1930-9. PubMed ID: 20857497
    [Abstract] [Full Text] [Related]

  • 13. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression.
    Abounader R, Ranganathan S, Lal B, Fielding K, Book A, Dietz H, Burger P, Laterra J.
    J Natl Cancer Inst; 1999 Sep 15; 91(18):1548-56. PubMed ID: 10491431
    [Abstract] [Full Text] [Related]

  • 14. Hepatocyte growth factor attenuates transforming growth factor-β-angiotensin II crosstalk through inhibition of the PTEN/Akt pathway.
    Iekushi K, Taniyama Y, Kusunoki H, Azuma J, Sanada F, Okayama K, Koibuchi N, Iwabayashi M, Rakugi H, Morishita R.
    Hypertension; 2011 Aug 15; 58(2):190-6. PubMed ID: 21670418
    [Abstract] [Full Text] [Related]

  • 15. Blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathways by statins reduces the expression of bFGF, HGF, and TGF-β as angiogenic factors in mouse osteosarcoma.
    Tsubaki M, Yamazoe Y, Yanae M, Satou T, Itoh T, Kaneko J, Kidera Y, Moriyama K, Nishida S.
    Cytokine; 2011 Apr 15; 54(1):100-7. PubMed ID: 21292498
    [Abstract] [Full Text] [Related]

  • 16. Hepatocyte growth factor promotes cell proliferation and inhibits progesterone secretion via PKA and MAPK pathways in a human granulosa cell line.
    Taniguchi F, Harada T, Deura I, Iwabe T, Tsukihara S, Terakawa N.
    Mol Reprod Dev; 2004 Jul 15; 68(3):335-44. PubMed ID: 15112327
    [Abstract] [Full Text] [Related]

  • 17. Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile response to Hepatocyte Growth Factor.
    Frasca F, Vigneri P, Vella V, Vigneri R, Wang JY.
    Oncogene; 2001 Jun 28; 20(29):3845-56. PubMed ID: 11439348
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of hepatocyte growth factor-mediated signaling in differentiation of pancreatic ductal epithelial cells into insulin-producing cells.
    Li XY, Zhan XR, Lu C, Liu XM, Wang XC.
    Biochem Biophys Res Commun; 2010 Jul 30; 398(3):389-94. PubMed ID: 20599723
    [Abstract] [Full Text] [Related]

  • 19. The phosphatidylinositol 3-kinase/Akt pathway regulates transforming growth factor-{beta} signaling by destabilizing ski and inducing Smad7.
    Band AM, Björklund M, Laiho M.
    J Biol Chem; 2009 Dec 18; 284(51):35441-9. PubMed ID: 19875456
    [Abstract] [Full Text] [Related]

  • 20. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
    Mut M, Lule S, Demir O, Kurnaz IA, Vural I.
    Int J Biochem Cell Biol; 2012 Feb 18; 44(2):302-10. PubMed ID: 22085529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.